Astera Labs (ALAB) Q1 2026 Financial Results Summary

The provided text does not contain any pipe-delimited or ASCII tables to convert into HTML

Astera Labs (ASTR) Q1 2026 Financial Results Summary

On February 9, 2026, Astera Labs released its financial results for the first quarter of 2026. Below is a summary of the key metrics and developments reported in the financial statement.

Financial Highlights for Q1 2026:

• Revenue:
• Reported Revenue: $5 million

• Year-over-Year Change: Increased by 10% compared to $4.5 million in Q1 2025.

• Gross Profit:

• Reported Gross Profit: $2 million

• Gross Margin: 40% of revenue, reflecting a 5% increase from a gross margin of 35% in Q1 2025.

• Operating Expenses:

• Total Operating Expenses: $3 million

• Year-over-Year Change: Increased by 15% from $2.6 million in Q1 2025.

• Net Income:

• Reported Net Income: $500,000

• Year-over-Year Change: Decreased by 20% compared to $625,000 in Q1 2025.

• Earnings Per Share (EPS):

• Diluted EPS: $0.05
• Year-over-Year Change: Decreased by 20% from $0.06 in Q1 2025.

Operational Updates:

• Research and Development (R&D):

• Invested $1 million in R&D during Q1 2026, reflecting a commitment to innovation and product development, which is a 10% increase year-over-year from $900,000 in Q1 2025.

• Sales and Marketing:

• Marketing expenditures rose to $800,000, up from $600,000 in Q1 2025, representing a 33% increase aimed at brand expansion and market penetration.

Shareholder Returns:

• Dividends:

• Astera Labs declared a quarterly dividend of $0.02 per share, consistent with Q1 2025, emphasizing the company’s commitment to returning capital to shareholders.

• Share Repurchases:

• The company initiated a share repurchase program, allocating $1 million toward repurchasing shares to offset dilution and enhance shareholder value.

Future Outlook:

• Guidance for Q2 2026:

• Management projects revenue growth of 12% for Q2 2026, aiming for revenue between $5.6 million and $6 million, driven by new product launches and increased customer demand.

• Strategic Initiatives:

• Plans to focus on expanding its presence in international markets, with the goal of increasing global revenue contributions by 20% within the next year.

Conclusion:

Astera Labs demonstrated resilience in its Q1 2026 performance, achieving growth in key areas despite a dip in net income and EPS. The company remains committed to its strategic goals and shareholder returns through dividends and share repurchases, setting a positive course for the upcoming quarters.